ResMed CFO Sells Shares
Published on 11/05/2025 at 08:38 am IST
MT Newswires
Share
Share
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 209.86 USD | +1.00% |
|
+3.70% | -12.87% |
| 20/05 | ResMed Rises After Partnership With Oura to Expand Sleep Health Education, Care Pathways | MT |
| 18/05 | Apnimed's sleep apnea pill meets main goal in late-stage study | RE |
![Brett Sandercock](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mr. Brett A. Sandercock is a Chief Financial Officer at ResMed, Inc. and a Non-Executive Chairman at Osteopore Ltd. Mr. Sandercock was previously employed as a Manager-Financial Accounting & Group Reporting by Norton Co., a Principal by Norton Co., a Group Management Accountant by Healthcare of Australia Pty Ltd., a Principal by PricewaterhouseCoopers (Australia), and a Non-Executive Director by CAP-XX Ltd. He received his undergraduate degree from Macquarie University.
Employees
10,600
Trader
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
A
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
209.86USD
Average target price
270.60USD
Spread / Average Target
+28.94%
Quarterly revenue - Rate of surprise
- Stock Market
- Stock Market News
- ResMed CFO Sells Shares
Select your edition
All financial news and data tailored to specific country editions
